大理药业,603963,收入构成,报告日期,2021-06-30, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中南,2528,-- ,2528,--,27.47% 西南,1203,-- ,1203,--,13.07% 西北,1299,-- ,1299,--,14.11% 华东,2447,-- ,2447,--,26.59% 华北,1017,-- ,1017,--,11.05% 东北,709,-- ,709,--,7.71% 大理药业,603963,收入构成,报告日期,2020-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中南,5460,1699,3761,68.88%,24.03% 西南,2885,670,2215,76.78%,14.15% 西北,3137,698,2440,77.76%,15.59% 其他(补充),2,-- ,2,--,0.01% 华东,5370,1632,3738,69.6%,23.88% 华北,2328,506,1822,78.27%,11.64% 东北,2176,501,1674,76.95%,10.7% 大理药业,603963,收入构成,报告日期,2019-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 西南,3502,809,2694,76.91%,12.18% 华北,3757,750,3006,80.03%,13.6% 西北,5486,1115,4371,79.68%,19.77% 东北,2789,556,2233,80.07%,10.1% 中南,5799,1763,4036,69.59%,18.25% 华东,8098,2329,5769,71.24%,26.09% 其他(补充),2,-- ,2,--,0.01% 大理药业,603963,收入构成,报告日期,2018-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 西北,4908,980,3928,80.03%,12.2% 东北,4300,686,3614,84.04%,11.22% 其他(补充),2,-- ,2,--,0.01% 西南,4183,911,3272,78.22%,10.16% 华北,5392,842,4549,84.38%,14.13% 中南,10105,1974,8130,80.46%,25.24% 华东,11260,2549,8710,77.36%,27.05% 大理药业,603963,收入构成,报告日期,2017-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 华北,4042,971,3071,75.97%,16.6% 中南,4692,2009,2682,57.17%,14.5% 华东,8353,3229,5124,61.35%,27.7% 西北,3580,881,2699,75.38%,14.59% 东北,3225,670,2555,79.21%,13.81% 其他(补充),1,-- ,1,--,0.01% 西南,3381,1014,2367,70%,12.79%